SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-116282
Filing Date
2016-08-03
Accepted
2016-08-03 17:01:43
Documents
52
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v444734_10q.htm 10-Q 399434
2 EXHIBIT 31.1 v444734_ex31-1.htm EX-31.1 13554
3 EXHIBT 31.2 v444734_ex31-2.htm EX-31.2 13429
4 EXHIBIT 32.1 v444734_ex32-1.htm EX-32.1 5248
5 EXHIBIT 32.2 v444734_ex32-2.htm EX-32.2 5162
6 GRAPHIC tpg16.jpg GRAPHIC 28913
  Complete submission text file 0001144204-16-116282.txt   3263708

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT syn-20160630.xml EX-101.INS 749494
8 XBRL TAXONOMY EXTENSION SCHEMA syn-20160630.xsd EX-101.SCH 33797
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20160630_cal.xml EX-101.CAL 30995
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20160630_def.xml EX-101.DEF 183617
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20160630_lab.xml EX-101.LAB 246604
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20160630_pre.xml EX-101.PRE 215300
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 161804645
SIC: 2834 Pharmaceutical Preparations